Branden Ryu

Branden Ryu

Company: Biorchestra Co. Ltd.

Job title: Founder and Chief Executive Officers


CNS Delivery of RNA Therapeutics Using LAT1 Target Polymeric Nanoparticle 11:00 am

Biorchestra Drug Delivery System (BDDSTM) is a proprietary technology utilizing non-lipid polymer ion complex and LAT1 targeting ligand for BBB penetration Preclinical assessment on ALS and Epilepsy of ASO therapeutics with BDDSTM technology BDDSTM technology is compatible with multiple RNA species with various lengths (e.g., ASO, siRNA & mRNA) and shows a therapeutic potency in…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.